IFNB1 and Cryptococcal meningitis: Adding TNF-α or IFN-β to our assays, at levels comparable to those seen in HIV-positive (HIV+) patients with cryptococcal meningitis (24, –, 26), yielded small but significant changes in barrier permeability (Fig. 3F and G), consistent with those reports.